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Abstract
BACKGROUND: While takotsubo cardiomyopathy (TCM) was initially considered a benign disease, recent studies 
have demonstrated poor cardiovascular outcomes. It is important to determine the predictors of these outcomes for 
appropriate risk stratification and to decrease the overall disease burden. Physical stressors (e.g., acute neurologic 
disorder and lung disorder) and pre-existing heart failure have been associated with worse outcomes. Alcohol abuse 
has been associated with cardiomyopathy and may also exacerbate pre-existing heart conditions. 
AIM: We aimed to determine the impact of alcohol abuse on patients with TCM.
METHODS: We identified 11,221 patients from the 2009 to 2012 National Inpatient Sample, of which 10,622 had 
TCM alone and 599 had TCM and alcohol use disorder (AUD). Our outcomes of interest were overall mortality, 
need for mechanical hemodynamic support (MHS), acute respiratory failure, sudden cardiac arrest, cardiogenic 
shock, stroke, and atrial fibrillation. All clinical characteristics were defined per the International Classification of 
Diseases 9th revision codes. Logistic regression was used to estimate the odds ratios of the outcomes in patients 
with concomitant TCM and AUD, compared to those with TCM without AUD while adjusting for confounders.
RESULTS: The mean age of the sample was 60.5 ± 11 for TCM with AUD and 56.0 ± 11 for TCM alone. There was no 
significant difference between the two groups in the rates of atrial fibrillation (10.4% vs. 8,5%; p = 0.134), cardiogenic 
shock (5.9% vs. 4.8%; p = 0.3), use of MHS (2.6% vs. 1.7%; p = 0.165), overall in-hospital mortality (4.0% vs. 3.7%; 
p = 0.691), stroke (1.6% vs. 1.3%; p = 0.593), and sudden cardiac arrest (2.7% vs. 3.5%; p = 0.24). Rates of acute 
respiratory failure (17.7% vs. 25.2%; p < 0.0001) were significantly higher in patients with TCM with AUD compared 
to those with TCM alone. After adjusting for significant cofounders, the odds ratio for respiratory failure among 
patients with concomitant TCM and AUD was 1.36 (95% CI: 1.11–1.66) compared to those with TCM without AUD.
CONCLUSION: Pre-existing AUD is associated with an increased risk for respiratory failure in a patient with TCM.
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Clinical factors such as older age, physical 
stressors, diabetes mellitus, and pre-existing heart failure 
have been associated with poor outcomes [4]. The impact 
of alcohol use on outcomes in patients with TCM has not 
been discussed. Oxidative stress and accelerated protein 
catabolism have been implicated in the pathogenesis of 
alcoholic cardiomyopathy [5], [6]. In addition, they might 
exacerbate pre-existing heart conditions which may 
delay recovery and lead poor outcomes in patients with 
TCM [5], [6]. We aim to determine the effects of alcohol 
use on outcomes among patients with TCM.
Methods
Study design
This is a cross-sectional study that used the 
discharge data from the National Inpatient Sample (NIS) 
Introduction
Takotsubo cardiomyopathy (TCM) or stress-
induced cardiomyopathy is a transient reversible myocardial 
dysfunction thought to be secondary to exaggerated 
myocardial catecholamine exposure [1]. Predominantly 
seen in post-menopausal female in the setting of emotional 
or physical stressors, it is an increasingly recognized cause 
of inpatient hospitalization in recent years [1], [2].
Although, initially considered a benign 
condition, multiple observational studies have 
consistently demonstrated increased mortality and 
morbidity in patients with TCM [3]. Notably, up to 20% of 
these patients will go on to develop cardiogenic shock, 
up to 15% will develop a cardiac arrhythmia, and 4.5% 
will develop stroke. Finally, the in-hospital mortality rate 
can be as high as 5% [3], [4]. In relation, it is important 
to determine the predictors of poor outcomes in this 
patient population, to allow appropriate risk stratification, 
mitigate the risks, and improve overall outcomes.
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database for the year 2009–2012. The NIS, Healthcare 
Cost and Utilization Project, agency for healthcare 
research and quality (AHRQ) is the largest all-payer 
inpatient database in the United States (US). The database 
contains a 20% stratified sample of all discharges from the 
US nonfederal short-term general hospitals, subspecialty 
hospitals, and public hospitals and is stratified based on 
the number of beds, ownership, hospital teaching status, 
US region, and state. Stratified random sampling ensures 
that the database is representative of the US population 
and accounts for 90% of all hospitalizations in the US after 
applying appropriate weights. The NIS includes information 
on demographic characteristics, hospital characteristics, 
up to 25 diagnostic and procedure codes based on the 
International Classification of Diseases 9th revision, 
Clinical Modification (ICD-9-CM), and outcomes based on 
patient discharge records. Each record represents a single 
hospitalization and thus, multiple records are possible for 
an individual with recurrent hospitalizations [7].
Study population, variables, and outcomes
We identified patients aged 18–75 years from 
the 2009 to 2012 NIS with the discharge diagnosis of 
TCM using ICD-9-CM code 429.83 (Figure 1). The study 
group consisted of patients with a diagnosis of both 
TCM and alcohol use disorder (AUD), while the control 
group included – patients with a diagnosis of TCM 
without AUD in any of their discharge codes. AUD was 
identified using the ICD-9-CM codes 305.00–305.03 and 
303.90–303.93 (supplementary Table 1). Demographics 
and primary prayer associated with each discharge 
diagnosis were identified from the NIS. Comorbidities 
were identified using the AHRQ comorbidity software. 
This software allows identification of comorbidities not 
related to the primary diagnosis that was present before 
admission [8]. Comorbidities chosen were those used in 
prior studies evaluating outcomes in patients with TCM 
[8], [9], [10]. The primary outcomes of interest included 
overall in-hospital mortality, atrial fibrillation, sudden 
cardiac arrest, cardiogenic shock, acute respiratory 
failure, stroke, and mechanical hemodynamic support 
(MHS). All clinical variables were defined by the ICD-
9-CM codes (See supporting information for ICD-9-CM 
codes of these variables).
Statistical analysis
All statistical analyses were performed using 
SPSS version 20. We compared baseline patient 
characteristics and outcomes between patients with 
concomitant TCM and AUD and those with TCM without 
AUD. Chi-square test of significance was used for 
categorical variables and independent sample t-test to 
compare for the continuous variable. Logistic regression 
analysis was used to estimate the adjusted odds ratios 
(aOR) the outcomes between these two groups patients. 
Covariates adjusted for were include age, sex, tobacco 
use, hypothyroidism, chronic kidney disease, obesity, 
chronic obstructive pulmonary disease, diabetes 
mellitus, hyperlipidemia, and coronary artery disease. 
Association of each outcome variable with AUD was 
reported as aOR with 95% confidence interval. A two-
tailed p < 0.05 was considered statistically significant.
Results
Baseline demographics
We identified 11,221 patients with a discharge 
diagnosis of TCM. Among these patients, 599 (5.3%) had 
AUD and 10,622 (94.6%) did not have AUD. The study 
sample was mostly female (86.6%, Table 1). The mean 
age of patients with AUD was significantly lower compared 
to patient without AUD (56.01 ± 11 vs. 60.47 ± 11; 
p < 0.0001). There were no significant racial differences 
between both groups. The prevalence of tobacco use 
disorder (45.9% vs. 19%; p < 0.0001) was significantly 
Table 1: Baseline characteristics of study participants by 
alcohol use disorder status
Demographics TCM ALONE (10,622) TCM + AUD (599) p-value
Age (years), mean (SD) 60.47 (11) 56.01 (11) <0.0001
Sex <0.0001
Female (n, %) 9297 (87.4) 427 (71.3)
Male (n, %) 1335 (12.6) 172 (28.7)
Race 0.159
White (n, %) 7629 (81.0) 447 (83.4)
Black (n, %) 725 (7.7) 45 (8.4)
Hispanic (n, %) 552 (5.9) 20 (3.7)
Asian or Pacific Islander (n, %) 187 (2.0) 5 (0.9)
Native America (n, %) 68 (0.7) 5 (0.9)
Other (n, %) 261 (2.8) 14 (2.6)
Primary prayer <0.0001
Medicare (n, %) 5093 (48.0) 207 (34.7)
Medicaid (n, %) 999 (9.4) 110 (18.4)
Private insurance (n, %) 3649 (34.4) 169 (28.3)
Self-pay (n, %) 522 (4.9) 77 (12.9)
No charge (n, %) 45 (0.4) 4 (0.7)
Other (n, %) 308 (2.9) 30 (5.0)
Comorbidities
Tobacco use disorder (n, %) 2023 (19) 275 (45.9) <0.0001
VHD (n, %) 82(0.8) 3(0.5) 0.457
Hypothyroidism (n, %) 1527 (14.4) 62 (10.4) 0.006
CKD (n, %) 850 (8.0) 20 (3.3) <0.0001
Obesity (n, %) 1136 (10.7) 28 (4.7) <0.0001
CHF (n, %) 2856 (26.9) 172 (28.7) 0.32
COPD (n, %) 2116 (19.9) 140 (23.4) 0.039
Hyperlipidemia (n, %) 3882 (36.5) 117 (19.5) <0.0001
Diabetes (n, %) 2640 (24.8) 112 (18.7) 0.001
Hypertension (n, %) 6380 (60.0) 339 (56.6) 0.097
CAD (n, %) 3660 (34.4) 182 (30.4) 0.043
AUD: Alcohol use disorder; CAD: Coronary artery disease; CKD: Chronic kidney disease; CHF: Congestive 
heart failure; COPD: Chronic obstructive pulmonary disease; SD: Standard deviation; TCM: Takotsubo 
cardiomyopathy; VHD: Valvular heart disease.
National Inpatient Sample  2009 - 2012
Indentified 11,221patients with a discharge 
diagnosis of TCM  using ICD-9-CM code 429.83
599 with a 
diagnosis of AUD.
10,622 without a 
diagnosis of AUD.
Figure 1: Selection of the patients
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higher in patients with AUD, while the prevalence of 
chronic kidney disease (3.3% vs. 8%; p < 0.0001), 
obesity (4.7% vs. 10.7%; p < 0.0001), hyperlipidemia 
(19.5% vs. 36.5%; p < 0.0001), diabetes mellitus (18.7% 
vs. 24.8%; p = 0.001), and hypothyroidism (10.4% vs. 
14.4%; p = 0.006) were significantly lower (Table 1).
Outcomes
There was no significant difference between the 
two groups in the rates of atrial fibrillation (10.4% vs. 8,5%; 
p = 0.134), cardiogenic shock (5.9% vs. 4.8%; p = 0.3), 
use of MHS (2.6% vs. 1.7%; p = 0.165), overall in
Table 2: Outcomes in patients with alcohol use disorder 
compared to those without alcohol use disorder
Outcomes TCM alone TCM+AUD p-value
Overall mortality (n, %) 425 (4.0) 22 (3.7) 0.691
Mechanical hemodynamic support (n, %) 275 (2.6) 10 (1.7) 0.165
Atrial fibrillation (n, %) 1109 (10.4) 51 (8.5) 0.134
Respiratory failure (n, %) 1880 (17.7) 151 (25.2) <0.0001
Cardiac arrest (n, %) 287 (2.7) 21 (3.5) 0.240
Cardiogenic shock (n, %) 623 (5.9) 29 (4.8) 0.300
Stroke (n, %) 172 (1.6) 8 (1.3) 0.593
TCM: Takotsubo cardiomyopathy; AUD: Alcohol use disorder. p < 0.05 means statistical significant. Rates 
of sudden cardiac arrest and acute respiratory failure was significantly higher in patients with alcohol use 
disorder.
hospital mortality (4.0% vs. 3.7%; p = 0.691), stroke 
(1.6% vs. 1.3%; p = 0.593), and sudden cardiac death 
(2.7% vs. 3.5%; p = 0.24). Rates of acute respiratory 
failure (25.2%, vs. 17.7%; p < 0.0001) were 
significantly higher in patients with AUD compared 
to those without AUD (Table 2 and Figure 2). After 
adjusting for covariates (Table 3), the
Table 3: Adjusted odds ratios and 95% confidence intervals for 
outcomes among those with alcohol use disorder compared to 
those without
Outcomes TCM aOR (95% CI) TCM+AUD p-value
Overall mortality 1.0 0.81 (0.52–1.26) 0.34
AF 1.0 1.21 (0.89–1.65) 0.22
Cardiac arrest 1.0 1.13 (0.71–1.78) 0.61
Cardiogenic shock 1.0 0.73 (0.50–1.08) 0.13
MHS 1.0 0.59 (0.31–1.11) 0.10
Respiratory failure 1.0 1.34 (1.11–1.66) 0.003
Stroke 1.0 0.72 (0.35–1.48) 0.36
AUD: Alcohol use disorder; CI: Confidence interval; AF: Atrial fibrillation; MHS: Mechanical hemodynamic 
support; Adjusted covariates include age, sex, tobacco use, hypothyroidism, chronic kidney disease, 
obesity, chronic obstructive pulmonary disease, diabetes mellitus, hyperlipidemia, and coronary artery 
disease.
odds ratio for acute respiratory failure (aOR 1.36; 95% CI: 
1.11–1.66) in patients with AUD compared to those without 
AUD remained significant. The association for the other 
outcomes was attenuated when adjusted for covariates.
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Figure 2: Proportion of outcomes by alcohol use disorder status. The 
vertical axis represents percentage of outcomes, while the horizontal 
axis, the specified outcomes, and corresponding p-values. TCM: 
Takotsubo cardiomyopathy, AUD: Alcohol use disorder
Discussion
In this study, we investigated the association 
between concomitant TCM and AUD compared to TCM 
without AUD and outcomes. We found a significant 
association between concomitant TCM and AUD and 
acute respiratory, with an estimated 36% increased risk, 
compared to those with TCM without AUD. There was 
no apparent association between concomitant TCM 
and AUD, and atrial fibrillation, stroke, sudden cardiac 
death, use of MHS, cardiogenic shock, or overall 
inpatient mortality. To our knowledge, this is the first 
study to evaluate the effects of AUD on TCM outcomes.
We have seen an increased incidence in TCM 
in recent years due to increased awareness and the wide 
availability of invasive coronary angiography [1]. While it 
was previously considered benign, recent studies have 
demonstrated rates of in-hospital complications similar 
to those in patients with acute coronary syndrome [11]. 
Ghadri et al. reported up to 15% rate of atrial fibrillation, 
20% cardiogenic shock, and 6% sudden cardiac arrest 
in these patients [4]. Common predictors of these 
outcomes include a physical stressor, age >75 years, 
male sex, reduction in left ventricular systolic function 
on admission, high brain natriuretic peptide levels, and 
a troponin >10 times the upper reference limit [4]. In a 
recent study, Desai et al. demonstrated an increased 
risk of cardiac complications in obese patients with 
TCM compared to non-obese patients [12].
Acute respiratory failure as an in-hospital 
complication in TCM has not been well studied. Prior 
studies looking at in-hospital complications in patients 
with TCM have focused on cardiac complications 
such as cardiogenic shock, cardiac arrest, myocardial 
infarction, and arrhythmias [11]. In our study, we 
found an 18% rate of acute respiratory failure among 
patients with TCM, which is higher than that reported 
in other studies evaluating acute respiratory failure as 
a complication of TCM [8], [9], [12]. Desai et al., while 
evaluating TCM complications in obese compared 
to non-obese patients, observed a 12% rate of acute 
respiratory failure, while Yassin et al. observed a 14% 
rate in another study evaluating the impact of atrial 
fibrillation on TCM [8], [12]. In our study, we found a 
25% prevalence of acute respiratory failure in patients 
with concomitant TCM and AUD, compared to 17.7% in 
those without AUD.
While the exact pathogenesis of TCM is unclear, 
it is thought to be secondary to exaggerated myocardial 
catecholamine exposure [3]. Furthermore, studies have 
suggested that oxidative stress may also play a role 
through inducing left ventricular dysfunction by affecting 
calcium homeostasis and myocardial contractile 
function [10], [13]. Chronic alcohol use weakens 
the pulmonary immune system and makes the cells 
more susceptible to oxidative stress injury, increasing 
the risk for acute respiratory distress syndrome and 
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pneumonia[14],[15],[16]. Another plausible explanation 
for the higher risk of acute respiratory failure seen 
in patients with concomitant TCM and AUD is that 
patients with AUD have an increased risk of aspiration 
pneumonia, which can eventually lead to acute 
respiratory failure [17]. Furthermore, oxidant injury might 
explain acute respiratory failure seen in patients with 
TCM and increased susceptibility to such injury might 
explain why the rates are higher in patients with AUD.
Limitations
Our study has some limitations related to the 
NIS database: (1) We identified patients with AUD using 
ICD-9-CM codes. We might have missed some patients 
with this condition in cases where the diagnosis was not 
coded. Furthermore, we were unable to quantify alcohol 
intake. (2) Information on laboratory and clinical data 
such as vital signs and left ventricular ejection fraction 
to determine the severity of TCM, was unavailable. This 
might play a role on the outcomes.
Conclusion
Our study showed that the risk of acute 
respiratory failure was significantly higher among 
patients with concomitant TCM and AUD compared 
to those without AUD. Future studies are needed to 
replicate our findings and further clarify the impact of 
AUD on outcomes in patients with TCM.
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Supplementary Table 1
International Classification of Disease 9th Revision –Clinical Modification Codes (ICD-9 CM) and Clinical 
Classifications Software and procedure (PR) codes used for Comorbidities and Complications not provided by NIS 
database
(The comorbidity codes provided by database: https://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/
Table2-FY2010-V3_5.pdf)
Comorbidities ICD-9 CM/CCS/PR codes
Tobacco use disorder 305.1
Valvular heart disease 424.0, 424.1, 424.2, 424.3
Hypothyroidism 244.9
Chronic kidney disease 585.1–585.5
Obesity 278.0–278.03
Hypertension 401.9
Congestive heart failure 428.0
Chronic obstructive pulmonary disease 491, 492
Diabetes 250.00–250.03
Hyperlipidemia 272.4
Coronary artery disease 414.01
Complications
Stroke 434.91
Atrial fibrillation 427.31
Cardiogenic shock 785.51
Cardiac arrest 427.5
Mechanical circulatory support (percutaneous ventricular 
assist device (Impella®), intra-aortic balloon pump
PR 37.68, PR 37.61
Respiratory failure 518.81
